Last reviewed · How we verify

Mistletoe extract (Iscador Qu) — Competitive Intelligence Brief

Mistletoe extract (Iscador Qu) (Mistletoe extract (Iscador Qu)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal immunotherapy agent. Area: Oncology.

phase 3 Herbal immunotherapy agent Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Mistletoe extract (Iscador Qu) (Mistletoe extract (Iscador Qu)) — Karolinska University Hospital. Mistletoe extract (Iscador Qu) stimulates the immune system to recognize and attack cancer cells through activation of natural killer cells and other immune effectors.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Mistletoe extract (Iscador Qu) TARGET Mistletoe extract (Iscador Qu) Karolinska University Hospital phase 3 Herbal immunotherapy agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal immunotherapy agent class)

  1. Karolinska University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Mistletoe extract (Iscador Qu) — Competitive Intelligence Brief. https://druglandscape.com/ci/mistletoe-extract-iscador-qu. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: